Search results
AMD STOPPER Offers New Hope to Sufferers of Age-Related Macular Degeneration | Healthcare Dive
Healthcare Dive· 21 hours agoFearful of losing all of his central vision to the gradual blinding effects of Age-Related Macular Degeneration (AMD), a California-based researcher with ...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WTNH-TV New Haven· 13 hours agoThe study enrolled patients with newly diagnosed wet AMD and active choroidal neovascularization (CNV), where anti-VEGF therapy was indicated.
No Difference in Kidney Failure Risk Between Three Anti-VEGF Agents for Eye Disease
MedPage Today· 2 weeks agoOf three anti-vascular endothelial growth factor (VEGF) drugs used to treat several serious eye...
Barclays initiates 4D Molecular stock with Overweight By Investing.com
Investing.com· 1 week agoThe firm's decision is rooted in the promising clinical profile of 4D Molecular Therapeutics'...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 6 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
The Hannibal Courier-Post· 6 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 6 days agoTherapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative ...
Health Care Roundup: Market Talk
The Wall Street Journal· 1 day agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
WJTV Jackson· 7 days agoNanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations ...
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
Zacks via Yahoo Finance· 2 weeks agoThe lawsuit was originally filed under the qui tam or whistleblower provisions of the FCA. Eylea is...
